The weekly litigation news digest is live. Subscribe now

IP Verse

Improved T Cell Manufacturing Process - EP3880802

The patent EP3880802 was granted to Celgene on Sep 7, 2022. The application was filed on Nov 15, 2019 under application number EP19821337A. The patent is currently recorded with a legal status of "Revoked".

EP3880802

CELGENE
Application Number
EP19821337A
Filing Date
Nov 15, 2019
Status
Revoked
Aug 1, 2025
Publication Date
Sep 7, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
BOULT WADE TENNANTJun 7, 2023BOULT WADE TENNANTADMISSIBLE

Patent Citations (13) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS5350674
DESCRIPTIONUS5585362
DESCRIPTIONUS5948893
DESCRIPTIONUS6326193
DESCRIPTIONUS6352694
DESCRIPTIONUS6534055
DESCRIPTIONUS6692964
DESCRIPTIONUS6887466
DESCRIPTIONUS6905681
DESCRIPTIONWO0129058
DESCRIPTIONWO0196584
INTERNATIONAL-SEARCH-REPORTUS2017313968
INTERNATIONAL-SEARCH-REPORTWO2015164745

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents